December 16, 2025

10x Genomics, Inc. (TXG) Stock Analysis: Exploring the 8.77% Potential Upside in Health Information Services

Investors with an eye on the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing prospect. Headquartered in Pleasanton, California, this life science technology company specializes in creating..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating a Challenging Landscape with Resilient Fundamentals

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has been drawing investor attention with its specialized focus on..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 70% Potential Upside Driven by Innovative Eye Therapies

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is gaining attention as a promising player in the biopharmaceutical sector, focusing on breakthrough therapies for eye conditions using its unique bioresorbable hydrogel-based formulation technology...

The Pennant Group, Inc. (PNTG) Investor Outlook: Exploring a 16.61% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.03 billion, this Idaho-based company..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 19.22% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, offers an intriguing prospect for investors with its potential upside of 19.22%. This Michigan-based..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a Potential 92.5% Upside Amidst Market Challenges

For investors keeping a close eye on the volatile biotechnology sector, Novavax, Inc. (NASDAQ: NVAX) presents a compelling, albeit risky, opportunity. Headquartered in Gaithersburg, Maryland, Novavax is a prominent player..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 77% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, particularly in the niche market of specialty and generic drug manufacturing. Based in Emeryville, California, this biopharmaceutical company..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unpacking the 7.21% Potential Upside

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a pioneer in the medical devices industry, has been gaining traction among investors with its promising market presence and growth potential. Headquartered in Alajuela,..

Opko Health, Inc. (OPK) Stock Analysis: Potential 163% Upside Captures Investor Attention

Opko Health, Inc. (NASDAQ: OPK) operates within the dynamic healthcare sector, specifically under the diagnostics and research industry. With a market capitalization of $1.07 billion, this Miami-headquartered company is making..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: A 55.70% Upside Potential in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) is a noteworthy contender in the healthcare sector, focusing on medical instruments and supplies with a market capitalization of approximately $957.56 million. The company’s innovative..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential in the Diagnostics & Research Sector

NeoGenomics, Inc. (NASDAQ: NEO) is capturing investor attention with its strategic positioning in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Fort Myers, Florida, NeoGenomics operates..

MiMedx Group, Inc (MDXG) Stock Analysis: Unpacking a 71% Potential Upside in the Booming Biotechnology Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a key player in the biotechnology sector, is making waves with an impressive potential upside of 71.35%. With a market capitalization of $1.05 billion, this..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Promising 89.53% Potential Upside in Biotech

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology firm, is capturing investor attention with its innovative approach to RNA medicine and a striking potential upside of 89.53%. As a..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 147% Potential Upside for Savvy Investors

Evolent Health, Inc. (NYSE: EVH) sits at a pivotal crossroads in the healthcare information services sector, offering a tantalizing potential upside of 147.05% according to analyst ratings. With a current..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring 11.70% Upside Potential

Guardian Pharmacy Services, Inc. (GRDN) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Based in Atlanta, Georgia, this company has carved a..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Unveiling an 81,958% Revenue Growth Opportunity

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has emerged as a compelling player in the biotechnology industry, capturing the attention of investors with its remarkable revenue growth and promising pipeline. Headquartered in..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Potential 42% Upside Sparks Investor Interest

Investors with a keen eye on the biotechnology sector may find Vera Therapeutics, Inc. (NASDAQ: VERA) an intriguing prospect. With a market capitalization of $3.49 billion, this clinical-stage biotechnology company..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Navigating a Promising 11% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the healthcare sector, operates at the intersection of medical care and facility management. With a market capitalization of $1.4 billion,..

agilon health, inc. (AGL) Stock Analysis: Navigating Healthcare’s Shifting Tides with a 45.53% Potential Upside

Investors looking into the healthcare sector might find agilon health, inc. (AGL) an intriguing, albeit challenging, opportunity. Specializing in managing healthcare services for seniors through primary care physicians, agilon health..

Indivior PLC (INDV) Stock Analysis: High Buy Ratings and a Strong Growth Trajectory

For investors eyeing potential growth within the healthcare sector, Indivior PLC (NASDAQ: INDV) presents a compelling case. Specializing in the development and manufacture of buprenorphine-based prescription drugs, Indivior has carved..

Search

Funds

December 16, 2025

Search

Funds

December 16, 2025

FTSE 100

Funds